The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2024 | Mortality trends in patients with myeloma with pneumonia, influenza, & COVID-19 from 1999-2022
Patients with multiple myeloma (MM) are at higher risk of severe infection due to an increased likelihood of being immunosuppressed. Harsh Parmar, MD, Hackensack University Medical Center, Hackensack, NJ, provides an insight into mortality trends in patients with myeloma with pneumonia, influenza, and COVID-19 between 1999 and 2022. This retrospective analysis utilized data from the Centers for Disease Control and Prevention (CDC) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
